US

Harry Brittain

This inventor holds 0 USPTO granted patents, plus 3 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Harry Brittain. Retrieved from https://idiyas.com/inventor/harry-brittain-lj0gaie9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

 

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: The Innovations of Harry Brittain

Introduction

Harry Brittain is an inventive mind based in the United States, known for his contributions to the field of therapeutic compounds. His work focuses on enhancing the administration of medications through innovative methods. Although he holds 0 patents, his research has significant implications for medical treatments.

Latest Patents

One of Brittain's notable inventions is titled "Compositions And Methods For Transmucosal Absorption." This invention provides compositions, uses, and methods for administering therapeutic compounds, specifically amitriptyline, for transmucosal absorption. The compositions include a basifying agent alongside the therapeutic agent, which offers surprising pharmacokinetic benefits over traditional oral administration. Additionally, methods for treating fibromyalgia in human subjects are also included in this invention.

Career Highlights

Throughout his career, Harry Brittain has focused on improving drug delivery systems. His innovative approaches aim to enhance the efficacy of treatments for various conditions, particularly fibromyalgia. His research has the potential to change how medications are administered and absorbed in the body.

Collaborations

Brittain has collaborated with notable colleagues in his field, including Seth Lederman and Giorgio Reiner. These partnerships have contributed to the development of his innovative methods and compositions.

Conclusion

Harry Brittain's work in the field of therapeutic compounds showcases his dedication to improving medical treatments. His innovative approaches to drug administration have the potential to significantly impact patient care and treatment outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…